BioSpace News Archive

Deals

Two Biotechs Prep IPOs to Start Off June

Eight biotechs launched initial public offerings (IPO) in May, April wasn’t as hot a month, with only two. But June is off to a good start with two.

June 4, 2018
·
3 min read
·
Mark Terry
Drug Development

ASCO 2018: Results Keep Rolling In

There’s plenty of news coming out of the American Society of Clinical Oncology (ASCO) Annual Meeting behind held in Chicago. Here’s a look at a few more of the top stories.

June 4, 2018
·
3 min read
·
Mark Terry
Drug Development

ASCO 2018: Some of the Top Stories So Far

With the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting ongoing, there are hundreds of newsworthy stories. Here is a few of our top picks so far.

June 4, 2018
·
4 min read
·
Mark Terry
Drug Development

Two Roche Cancer Drugs Get Disappointing Results

Bad news for Roche Holding AG. Two of its cancer drugs, Tecentriq and taselisib, have been shown to provide only modest protection from disease progression.

June 4, 2018
·
2 min read
·
Don McCormick
Genetown

BIO 2018 is the International Convention’s 25th Year

The 2018 BIO International Convention will be officially running from June 4 through June 7 and is celebrating 25 years of innovation.

June 4, 2018
·
3 min read
·
Mark Terry
Business

Blueprint and CStone Team Up to Bring Cancer Medicines to China

Blueprint Medicines Corporation and privately held CStone Pharmaceuticals have entered into a partnership to develop and commercialize avapritinib, BLU-554 and BLU-667 in mainland China, Hong Kong, Macau and Taiwan, either as monotherapies or combination therapies.

June 4, 2018
·
2 min read
·
Don McCormick
Drug Development

Shuttered, Closed, Halted and Killed: Biopharma Companies End Programs

BioSpace takes a look at some notable programs that have been shuttered so far this year.

June 4, 2018
·
4 min read
·
Mark Terry
Targovax to Present at Jefferies 2018 Global Healthcare Conference

Targovax ASA announces that CMO Magnus Jäderberg will present a company overview at the Jefferies 2018 Global Healthcare Conference.

June 4, 2018
·
2 min read
Drug Development

ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma

CarThera announced the preliminary data of its Phase I/IIa clinical trial (NCT02253212) on ultrasound induced blood-brain barrier (BBB) opening.

June 4, 2018
·
4 min read
Business

RiseNow Welcomes Two Experts to Team

RiseNow, LLC is proud to announce the addition of two new specialists to the RiseNow team.

June 4, 2018
·
2 min read